Generate Biomedicines, Inc. IPO Research Information

Generate Biomedicines, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Generate Biomedicines, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Generate Biomedicines, Inc.	GENB - NASDAQ	$15.00-$17.00	$16.00	$15.00	25 million	2/27/2026
Underwriter(s): Goldman Sachs, Morgan Stanley, Piper Sandler, Guggenheim Securities, Cantor
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2026-02-04 Terms Added 2026-02-23

Generate Biomedicines, Inc. Quote & Chart - Click for current quote - GENB

About Generate Biomedicines, Inc. (adapted from Generate Biomedicines, Inc. prospectus):
They are a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "GENB" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.